91 results
Page 2 of 5
8-K
EX-99.1
5tf753 vy
15 May 23
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
8:01am
PRE 14A
za8op6tu4rlt njpswx
14 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
9969imnzr 37
30 Mar 23
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:32pm
8-K
EX-99.1
gwlhf
8 Nov 22
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm
S-8
EX-99.1
jk2xur
31 Aug 22
Registration of securities for employees
4:32pm
8-K
EX-99.1
duk1egwraw
8 Aug 22
Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones
4:32pm
8-K
mrg18k5cq8j07y8la
26 Jul 22
Other Events
4:02pm
8-K
EX-99.1
ouurzzf
9 May 22
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
4:31pm
POS AM
gle541a
28 Feb 22
Prospectus update (post-effective amendment)
5:46pm
8-K
EX-99.1
vwpr9
28 Feb 22
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
4:36pm
POSASR
ixitjyz14i birx4w6i
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:16pm
8-K
EX-99.1
p7wok4yniptg44qwj06
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
vfhjtx x8n
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm